However, there are certain criteria that healthcare providers typically consider when determining if Semaglutide is the right choice for a patient: Body Mass Index (BMI): Semaglutide is generally recommended for individuals with a BMI of 30 or higher (classified as obese) or a BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
Non-oral contraceptives, such as the implant, injection, hormonal coil, or patch, arent affected by either medication, because they dont rely on absorption through the gut
Tirzepatide targets both the GLP 1 and the GIP receptor agonist, while semaglutide mimics only the GLP-1 receptor agonist, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver
T., Stanczyk, F., Hoover, R